Fellowship · Seattle, WA
Sponsored by University of Washington School of Medicine
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
The Lancet. Neurology · 2023 · 218 citations · Michael Weiss
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.
Neurology · 2024 · 70 citations · Seth Perlman
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
JAMA neurology · 2022 · 114 citations · Seth Perlman
Targeted long-read sequencing identifies missing disease-causing variation.
American journal of human genetics · 2021 · 181 citations · Seth Perlman
The spatial landscape of glial pathology and T cell response in Parkinson's disease substantia nigra.
Nature communications · 2025 · 31 citations · Maxwell Ma
Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.
Therapeutic advances in neurological disorders · 2024 · 35 citations · Michael Weiss
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
JAMA neurology · 2021 · 118 citations · Michael Weiss
Neuropsychological Outcomes in 6-Year-Old Children of Women With Epilepsy: A Prospective Nonrandomized Clinical Trial.
JAMA neurology · 2025 · 20 citations · Jeffrey Tsai